Top Markets
#1 Derive Derive +33.82%
#2 Cross Cross +15.09%
#3 Geodnet Geodnet +13.37%
#4 Gama Token Gama Token +9.17%
#5 Talus Network Talus Network +8.96%
#6 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.42%
#7 Cap Cap +6.96%
#8 Audiera Audiera +5.78%
#9 OVERTAKE OVERTAKE +5.63%
#10 Ontology Gas Ontology Gas +5.54%
Coin of the day
Derive Derive
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Core One Labs Inc. Core One Labs Inc.

Core One Labs Inc.

COOL
Classement en actions #36380
Core One Labs Inc. functions as a biotechnology research and life sciences... Core One Labs Inc. functions as a biotechnology research and life sciences firm. Its primary objective involves bringing psychedelic medications to the market, employing several key strategies. These include developing innovative delivery methods, offering psychedelic-assisted psychotherapy, and manufacturing API-grade psilocybin. The company also developed CannaStrips technology, which facilitates the bioavailability of cannabis compounds through infused strips. Complementing its core activities, Core One Labs provides a range of additional services such as consulting, financing, and micro cultivation support. It further operates medical and wellness clinics, supplies natural health products, and offers news dissemination services. Established in 2010, the company, formerly known as Lifestyle Delivery Systems Inc., adopted its current name in September 2019 and is headquartered in Vancouver, Canada.
Prix de l'action
$0.10745118
Dernière synchronisation: 2024-08-30
Capitalisation boursière
$2.75M
Changement (1 jour)
-0.06%
Changement (1 an)
0.00%
Pays
CA
Échange Core One Labs Inc. (COOL)

Catégorie

Healthcare
Bénéfices pour Core One Labs Inc. (COOL)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Core One Labs Inc., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Core One Labs Inc. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE